VISTA agonist (Protheragen)

N/A

Report date: 2025/03/20 09:15:56

NME

Base Information

Drug NameVISTA agonist (Protheragen)

Drug Alias NameV-domain immunoglobulin suppressor of T-cell activation (Protheragen)V-set immunoregulatory receptor agonist (Protheragen)compound-0056

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionV-domain Ig suppressor of T-cell activation stimulants

TargetsV-domain Ig suppressor of T-cell activation

Therapy Area/IndicationsAutoimmune DiseasesPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProtheragen Inc

China Registration ClassN/A

Develop Information

Active CompaniesProtheragen Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesPsoriasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A